New Leaf Venture Associates II, L.P. insider trades: Principia Biopharma (PRNB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where New Leaf Venture Associates II, L.P. reports to the SEC
and 2 more companies
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 13, 2019 | PRNB | ↓ Sell | 300,000 | $35.00 | $10.5M | Indirect | Aug 15, 2019 (2d) |
| Sep 18, 2018 | PRNB | ↑ Buy | 270,000 | $17.00 | $4.6M | Indirect | Sep 20, 2018 (2d) |
| Oct 25, 2016 | IRTC | ↑ Buy | 25,000 | $17.00 | $425K | Direct | Oct 25, 2016 (0d) |
| Mar 24, 2015 | MEIP | ↓ Sell | 1,601,390 | $1.97 | $3.2M | Direct | Mar 26, 2015 (2d) |
| Dec 18, 2014 | VSAR | ↓ Sell | 150,000 | $19.01 | $2.9M | Direct | Dec 22, 2014 (4d) |
| Dec 9, 2014 | MEIP | ↓ Sell | 79,085 | $6.01 | $476K | Direct | Dec 10, 2014 (1d) |
| Nov 11, 2014 | VSAR | ↓ Sell | 800,000 | $19.37 | $15.5M | Direct | Nov 13, 2014 (2d) |
| Sep 29, 2014 | VSAR | ↓ Sell | 12,556 | $20.02 | $251K | Direct | Oct 1, 2014 (2d) |
| Mar 27, 2014 | VSAR | ↑ Buy | 60,000 | $21.02 | $1.3M | Direct | Mar 28, 2014 (1d) |
| Nov 21, 2013 | MEIP | ↓ Sell | 365,000 | $8.25 | $3.0M | Direct | Nov 25, 2013 (4d) |
| May 8, 2013 | MEIP | ↓ Sell | 200,000 | $8.57 | $1.7M | Direct | May 8, 2013 (0d) |
| Apr 19, 2013 | MEIP | ↓ Sell | 257,300 | $8.48 | $2.2M | Direct | Apr 22, 2013 (3d) |
| Feb 19, 2013 | MEIP | ↓ Sell | 497,225 | $6.72 | $3.3M | Direct | Feb 20, 2013 (1d) |
| Jul 24, 2012 | DRTX | ↑ Buy | 784,313 | $9.00 | $7.1M | Indirect | Jul 26, 2012 (2d) |
| Oct 19, 2010 | WHRT | ↑ Buy | 2,341,920 | $2.13 | $5.0M | Direct | Oct 21, 2010 (2d) |
| Jan 26, 2010 | WHRT | ↑ Buy | 388,350 | $5.15 | $2.0M | Direct | Jan 28, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About New Leaf Venture Associates II, L.P.'s insider trades
New Leaf Venture Associates II, L.P. is a 10% owner of Principia Biopharma (PRNB). Since Jan 26, 2010, it has reported 6 open-market purchases worth $20.3M and 10 sales worth $43.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (5 filings), other transactions (3 filings), shares returned to the company (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRNB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.